Osteoporosis in men: A review of endogenous sex hormones and testosterone replacement therapy

Journal of Pharmacy Practice

Volumn 24, Issue 3, 2011, Pages 307-315

  Martin, Andrew C ^a  

^a UNION UNIVERSITY   (United States)

Author keywords

bone mineral density; fracture; osteoporosis; testosterone; testosterone replacement therapy

Indexed keywords

ANASTROZOLE; ANDROSTANOLONE; BIOLOGICAL MARKER; ESTRADIOL; ESTROGEN; ESTRONE; GOSERELIN; LETROZOLE; LEUPRORELIN; OSTEOCALCIN; PLACEBO; SEX HORMONE; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE; TRANSCRIPTION FACTOR PAX5;

APNEA; APPLICATION SITE REACTION; BONE DENSITY; BONE TURNOVER; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; FRACTURE; HEMATOCRIT; HIP; HORMONE SUBSTITUTION; HUMAN; LIVER FUNCTION TEST; LUMBAR SPINE; METABOLIC SYNDROME X; OSTEOLYSIS; OSTEOPOROSIS; PHARMACIST; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REVIEW; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE SYNTHESIS; TREATMENT OUTCOME;

EID: 79958167169     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190010397716     Document Type: Review

References (65)

1. Osteoporosis. CDC National Health and Nutrition Examination Survey web site. http://www.cdc.gov/nchs/data/nhanes/databriefs/osteoporosis.pdf. Accessed Oct 14, 2010
2. Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States,2005-2025. J Bone Miner Res. 2007 ; 22 (3). 465-475 (Pubitemid 46797130)
3. Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008 ; 23 (2). 205-214 (Pubitemid 351160034)
4. Cawthon PM, Ewing SK, McCulloch CE. et al;. Loss of hip BMD in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res. 2009 ; 24 (10). 1728-1735
5. Khosla S Osteoporosis Update. RP Robertson S Khosla, ed. Chevy Chase, MD: The Endocrine Society ; 2010 :
6. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2010 ; 95 (6). 2536-2559
7. Khosla S, Melton LJ, Atkinson EJ, et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab. 1998 ; 83 (7). 2266-2274 (Pubitemid 28503012)
8. Orwoll E, Lambert LC, Marshall LM, et al. Testosterone and estradiol among older men. J Clin Endocrinol Metab. 2006 ; 91 (4). 1336-1344
9. Hofbauer LC, Schoppet M Osteoporosis Update. RP Robertson S Khosla, ed. Chevy Chase, MD: The Endocrine Society ; 2010 :
10. Kenny AM, Raisz LG Androgens in Health and Disease. CJ Bagatell WJ Bremner, ed. Totawa, NJ: Humana Press ; 2003: 221-232.
11. Orwoll E, Blank JB, Barrett-Connor E, et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials. 2005 ; 26 (5). 569-585 (Pubitemid 41242402)
12. Blank JB, Cawthon PM, Carrion-Petersen ML, et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials. 2005 ; 26 (5). 557-568 (Pubitemid 41242401)
13. Barrett-Connor E, Nielson CM, Orwoll E, et al. Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ. 2010 ; 340: c1069
14. Bauer DC, Garnero P, Harrison SL, et al. Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. J Bone Miner Res. 2009 ; 24 (12). 2032-2038
15. Nielson CM, Bouxsein ML, Freitas SS, et al. Trochanteric soft tissue thickness and hip fracture in older men. J Clin Endocrinol Metab. 2009 ; 94 (2). 491-496
16. Black DM, Bouxsein ML, Marshall LM, et al. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J Bone Miner Res. 2008 ; 23 (8). 1326-1333 (Pubitemid 352040188)
17. Eriksson AL, Lorentzon M, Mellström D, et al. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab. 2006 ; 91 (12). 5029-5037 (Pubitemid 44917346)
18. Grundberg E, Lau EM, Lorentzon M, et al. Large-scale association study between two coding LRP5 gene polymorphisms and bone phenotypes and fractures in men. Osteoporos Int. 2008 ; 19 (6). 829-837
19. Lewis CE, Ewing SK, Taylor BC, et al. Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res. 2007 ; 22 (2). 211-219 (Pubitemid 46167791)
20. Ferrar L, Jiang G, Cawthon PM, et al. Identification of vertebral fracture and non-osteoporotic short vertebral height in men: the MrOS study. J Bone Miner Res. 2007 ; 22 (9). 1434-1441 (Pubitemid 351339688)
21. Cummings SR, Cawthon PM, Ensrud KE, et al. BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res. 2006 ; 21 (10). 1550-1556 (Pubitemid 44484599)
22. Bauer DC, Ewing SK, Cauley JA, et al. Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporos Int. 2007 ; 18 (6). 771-777 (Pubitemid 46684789)
23. Lim LS, Fink HA, Kuskowski MA, et al. Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med. 2008 ; 168 (7). 735-740 (Pubitemid 351563957)
24. Ishani A, Paudel M, Taylor BC, et al. Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int. 2008 ; 19 (11). 1549-1556
25. Fink HA, Kuskowski MA, Taylor BC, et al. Association of Parkinson's disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporos Int. 2008 ; 19 (9). 1277-1282
26. Farhat GN, Taioli E, Cauley JA, et al. The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev. 2009 ; 18 (1). 148-154
27. Amin S, Zhang Y, Sawin CT, et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med. 2000 ; 133 (12). 951-963 (Pubitemid 32003511)
28. Szulc P, Munoz F, Claustrat B, et al. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab. 2001 ; 86 (1). 192-199 (Pubitemid 32109796)
29. Szulc P, Claustrat B, Marchand F, et al. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab. 2003 ; 88 (11). 5240-5247 (Pubitemid 37452722)
30. Khosla S, Melton LJ, Atkinson EJ, et al. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab. 2001 ; 86 (8). 3555-3561 (Pubitemid 32755943)
31. Falahati-Nini A, Riggs BL, Atkinson EJ, et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000 ; 106 (12). 1553-1560 (Pubitemid 32038592)
32. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003 ; 88 (1). 204-210 (Pubitemid 36115166)
33. Ensrud KE, Lewis CE, Lambert LC, et al. Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. Osteoporos Int. 2006 ; 17 (9). 1329-1336 (Pubitemid 44127319)
34. Ensrud KE, Fullman RL, Barrett-Connor E, et al. Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. J Clin Endocrinol Metab. 2005 ; 90 (4). 1998-2004 (Pubitemid 40586231)
35. Vandenput L, Labrie F, Mellström D, et al. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J Bone Miner Res. 2007 ; 22 (2). 220-227 (Pubitemid 46167792)
36. Barrett-Connor E, Mueller JE, von Mühlen DG, et al. Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2000 ; 85 (1). 219-223 (Pubitemid 32268817)
37. Center JR, Nguyen TV, Sambrook PN, et al. Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J Bone Miner Res. 2000 ; 15 (7). 1405-1411 (Pubitemid 30413875)
38. Meier C, Nguyen TV, Handelsman DJ, et al. Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med. 2008 ; 168 (1). 47-54
39. Mellström D, Johnell O, Ljunggren O, et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res. 2006 ; 21 (4). 529-535
40. Mellström D, Vandenput L, Mallmin H, et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res. 2008 ; 23 (10). 1552-1560
41. LeBlanc ES, Wang PY, Janowsky JS, et al. Association between sex steroids and cognition in elderly men. Clin Endocrinol (Oxf). 2010 ; 72 (3). 393-403
42. Anderson FH, Francis RM, Faulkner K. Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. Bone. 1996 ; 18 (2). 171-177 (Pubitemid 26092597)
43. Anderson FH, Francis RM, Peaston RT, et al. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J Bone Miner Res. 1997 ; 12 (3). 472-478 (Pubitemid 27120485)
44. Katznelson L, Finkelstein JS, Schoenfeld DA, et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996 ; 81 (12). 4358-4365 (Pubitemid 26412044)
45. Kenny AM, Prestwood KM, Raisz LG. Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels. Endocr Res. 2000 ; 26 (2). 153-168 (Pubitemid 30460837)
46. Snyder PJ, Peachey H, Berlin JA, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab. 2000 ; 85 (8). 2670-2677 (Pubitemid 32269134)
47. Snyder PJ. Effects of age on testicular function and consequences of testosterone treatment. J Clin Endocrinol Metab. 2001 ; 86 (6). 2369-2372 (Pubitemid 32545679)
48. Wang C, Swerdloff RS, Iranmanesh A, et al. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf). 2001 ; 54 (6). 739-750 (Pubitemid 34208885)
49. Tracz MJ, Sideras K, Boloña ER, et al. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab. 2006 ; 91 (6). 2011-2016 (Pubitemid 43854973)
50. Isidori AM, Giannetta E, Pozza C, et al. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Invest. 2005 ; 28 (10 suppl). 73-79
51. Amory JK, Watts NB, Easley KA, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab. 2004 ; 89 (2). 503-510 (Pubitemid 38269849)
52. Crawford BA, Liu PY, Kean MT, et al. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab. 2003 ; 88 (7). 3167-3176 (Pubitemid 36877490)
53. Fairfield WP, Finkelstein JS, Klibanski A, et al. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab. 2001 ; 86 (5). 2020-2026 (Pubitemid 32472914)
54. Hall GM, Larbre JP, Spector TD, et al. A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br J Rheumatol. 1996 ; 35 (6). 568-573
55. Howell SJ, Radford JA, Adams JE, et al. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin Endocrinol (Oxf). 2001 ; 55 (3). 315-324 (Pubitemid 32823041)
56. Kenny AM, Prestwood KM, Gruman CA, et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci. 2001 ; 56 (5). M266 - M272
57. Reid IR, Wattie DJ, Evans MC, et al. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med. 1996 ; 156 (11). 1173-1177 (Pubitemid 26196245)
58. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab. 1999 ; 84 (6). 1966-1972 (Pubitemid 30647018)
59. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992 ; 75 (4). 1092-1098
60. Morley JE, Perry HM 3rd, Kaiser FE, et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 1993 ; 41 (2). 149-152 (Pubitemid 23051423)
61. Christmas C, O'Connor KG, Harman SM, et al. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol A Biol Sci Med Sci. 2002 ; 57 (1). M12 - M18
62. Meier C, Liu PY, Ly LP, et al. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab. 2004 ; 89 (6). 3033-3041 (Pubitemid 38766405)
63. Merza Z, Blumsohn A, Mah PM, et al. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Int J Androl. 2006 ; 29 (3). 381-391 (Pubitemid 43736299)
64. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA. 2008 ; 299 (1). 39-52
65. Basurto L, Zarate A, Gomez R, et al. Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men. Aging Male. 2008 ; 11 (3). 140-145